Creo Medical Group PLC
F:1RC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Creo Medical Group PLC
F:1RC
|
UK |
|
B
|
Burcon NutraScience Corp
XBER:BNE
|
CA |
|
C
|
Citigroup Inc
LSE:0R01
|
US |
|
C
|
CITIC Ltd
OTC:CTPCY
|
CN |
|
Macrotech Developers Ltd
BSE:543287
|
IN |
|
F
|
Fairfax Financial Holdings Ltd
SWB:FFX
|
CA |
|
P
|
Pfizer Inc
XMUN:PFE
|
US |
|
Washington H Soul Pattinson and Company Ltd
ASX:SOL
|
AU |
|
R
|
Reckitt Benckiser Group PLC
F:3RBB
|
UK |
|
C
|
Ciena Corp
XHAM:CIE1
|
US |
|
B
|
Berkshire Hathaway Inc
SWB:BRYN
|
US |
Shareholder Yield
Current shareholder yield for 
1RC is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
1RC Price
Creo Medical Group PLC
| Average Annual Return | -17.22% |
| Standard Deviation of Annual Returns | 79.92% |
| Max Drawdown | -96% |
| Market Capitalization | 52.1m EUR |
| Shares Outstanding | 361 251 000 |
| Percentage of Shares Shorted |
N/A
|
